ghk-cu immunogenicity antibodies topical Frontiers GHK-Cu Topical Cream & Consultation

Kwon, D.R., & Park, G.Y

[12] What little has appeared since is preclinical and mostly concerns engineered analogues rather than DSIP itself for instance, fusion constructs designed to survive in circulation and cross the blood-brain barrier, tested in chemically-induced insomnia models in mice

Pre-filling syringes reduces effective dose by 58% over 24 hours due to peptide adhesion to syringe walls, which compounds across multi-day protocols and undermines dosing consistency

AOD-9604 is a research peptide commonly investigated in laboratory environments involving peptide signaling and metabolic pathway research applications

It can also be compounded for injection